The Effect of Traditional Chinese Medicine Combined With Cardiac Rehabilitation on Cardiac Function and Quality of Life in Patients after TAVR: a Randomized Controlled Trial

Phase 1

Recruiting

• Conditions: Valvular heart disease

• Registration Number: ITMCTR1900002648
• Lead Sponsor: Xiyuan Hospital, China Academy of Chinese Medical Sciences

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Last Update Posted: 20 February 2023

Recruitment & Eligibility

• Status: Recruiting
• Sex: All
• Target Recruitment: Not specified

Inclusion Criteria

1. 3-5 days after TAVR;
2. Qi and Blood Deficiency and Stasis Blocking Water Stopping Syndrome;
3. Subjects were informed and voluntarily signed informed consent.

Exclusion Criteria

1. Severe postoperative complications: acute heart failure, myocardial infarction, III degree atrioventricular block, and other malignant arrhythmias, aortic dissection;
2. Liver dysfunction (ALT or AST level is 2 times higher than normal value) and renal impairment (serum creatinine level is 2 times higher than normal value);
3. Patients with specific bleeding history or bleeding history due to warfarin use;
4. Patients taking other Chinese medicines within 90 days;
5. Anaphylaxis with known or suspected ingredients in Chinese herbal prescriptions.

Study & Design

• Study Type: Interventional study
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Six minute walk test;

Secondary Outcome Measures

Name	Time	Method
TCM symptom score;Comprehensive geriatric assessment;physicochemical indexes;